EUVIMEDEUVIMED entdecken
Open Access

Metabologenomic characterization uncovers a clinically aggressive IDH mutant glioma subtype

Farshad Nassiri, Andrew Ajisebutu, Vikas Patil, Yasin Mamatjan, Jeff Liu, Justin Z Wang, Mathew R Voisin, Romina Nejad, Sheila Mansouri, Shirin Karimi, Ankur Chakravarthy, Eric Chen und 3 weitere

Acta Neuropathologica · 2024-06 · 147 (1)

DOI: 10.1007/s00401-024-02713-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Neuropathologica, online erschienen am 07.04.2024. Verfasst von Farshad Nassiri und 14 weiteren Autor:innen. Beteiligte Einrichtung: Princess Margaret Cancer Centre, MacFeeters Hamilton Neuro-Oncology Program, University Health Network and University of Toronto, Toronto, ON, Canada…. Hauptthemen laut MEDLINE: Isocitrate Dehydrogenase, Glioma. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Canadian Cancer Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Isocitrate DehydrogenaseGliomaHumansEpigenomicsMutationTranscriptome

Substanzen

Isocitrate Dehydrogenase

Autor:innen und Institutionen

  • Princess Margaret Cancer Centre, MacFeeters Hamilton Neuro-Oncology Program, University Health Network and University of Toronto, Toronto, ON, Canada. farshad.nassiri@uhn.ca.
  • Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, ON, Canada. farshad.nassiri@uhn.ca.
  • Princess Margaret Cancer Centre, MacFeeters Hamilton Neuro-Oncology Program, University Health Network and University of Toronto, Toronto, ON, Canada.
  • Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, ON, Canada.
  • Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.

Förderung

  • NCI NIH HHS
  • Canadian Cancer Society

Zitieren

APA

Nassiri, F., Ajisebutu, A., Patil, V., Mamatjan, Y., Liu, J., Wang, J. Z., Voisin, M. R., Nejad, R., Mansouri, S., Karimi, S., Chakravarthy, A., Chen, E., De Carvalho, D. D., Aldape, K., & Zadeh, G. (2024). Metabologenomic characterization uncovers a clinically aggressive IDH mutant glioma subtype. Acta Neuropathologica, 147(1). https://doi.org/10.1007/s00401-024-02713-1

Vancouver

Nassiri F, Ajisebutu A, Patil V, Mamatjan Y, Liu J, Wang JZ, et al. Metabologenomic characterization uncovers a clinically aggressive IDH mutant glioma subtype. Acta Neuropathologica. 2024;147(1). doi:10.1007/s00401-024-02713-1

BibTeX
@article{Nassiri2024,
  author = {Nassiri, Farshad and Ajisebutu, Andrew and Patil, Vikas and Mamatjan, Yasin and Liu, Jeff and Wang, Justin Z and Voisin, Mathew R and Nejad, Romina and Mansouri, Sheila and Karimi, Shirin and Chakravarthy, Ankur and Chen, Eric and De Carvalho, Daniel D and Aldape, Kenneth and Zadeh, Gelareh},
  title = {Metabologenomic characterization uncovers a clinically aggressive IDH mutant glioma subtype},
  journal = {Acta Neuropathologica},
  year = {2024},
  volume = {147},
  number = {1},
  doi = {10.1007/s00401-024-02713-1}
}
Kostenlos starten →